DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Moreover, it is alarming the reduced number of countries providing the DMD full mutational analysis to the affected individuals, which, as it was highlighted throughout the manuscript, is now considered the foundations of the theragnosis for dystrophinopathies.